While statins can reduce LDL levels and ASCVD events, high Lp(a) poses an independent risk that will need attention, too.

Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.

Results demonstrated the mean total medical costs per patient per year decreased significantly after patients began ...

Leerink Partners analyst Thomas Smith has reiterated their bullish stance on TRML stock, giving a Buy rating yesterday. Thomas Smith’s ...